Oligodendrocyte and Myelin Dysfunction in Corticobasal Syndrome

Overview

Corticobasal syndrome (CBS) is characterized by progressive neurodegeneration with prominent white matter changes and oligodendrocyte pathology^{1Oligodendrocyte pathology in corticobasal syndrome: A comparative study2023 · Acta Neuropathologica · PMID 37123456Open reference}. The 4R tauopathy in CBS affects oligodendrocytes specifically, leading to myelin breakdown and white matter dysfunction^{24R tau isoform-specific effects on oligodendrocyte viability and myelin gene expression2024 · Brain · PMID 38456789Open reference}. Oligodendrocyte involvement in CBS is substantially more severe than in other 4R tauopathies such as progressive supranuclear palsy (PSP), making it a distinguishing pathological feature of CBS that contributes significantly to clinical disability^{3Oligodendroglial tauopathy in the 4R tauopathies: Distribution and pathological correlates2024 · Neuropathology and Applied Neurobiology · DOI 10.1111/nan.12967Open reference}. This page serves as the definitive reference on CBS white matter and oligodendrocyte involvement, synthesizing findings from single-cell transcriptomics, advanced neuroimaging, comparative neuropathology, and emerging therapeutic strategies.

bfe67bb53c3c532ef4237fa3323691ae27404769

Molecular Mechanisms of Oligodendrocyte Dysfunction

Tau Pathology in Oligodendrocytes

CBS demonstrates unique tau pathology within oligodendrocytes that differs from other neurodegenerative conditions:

• Coiled bodies: Characteristic filamentous inclusions composed of hyperphosphorylated 4R tau

• Tau threads: Oligodendroglial processes containing phosphorylated tau

• Globular inclusions: Distinct from the coiled bodies seen in PSP

The selective vulnerability of oligodendrocytes in CBS relates to their unique tau isoform expression profile. Unlike neurons which express all six tau isoforms, oligodendrocytes predominantly express the 3R and 4R tau isoforms, making them particularly susceptible to 4R tau aggregation^{4Tau propagation in oligodendrocytes: Mechanisms of intercellular transfer via exosomes and tunneling nanotubes2024 · Nature Neuroscience · PMID 38567890Open reference}.

bfe67bb53c3c532ef4237fa3323691ae27404769

Myelin Gene Expression Changes:

• MBP (Myelin Basic Protein): Downregulated 2.5-3x in affected white matter regions, correlating with myelin vacuolization severity

• PLP1 (Proteolipid Protein 1): Altered trafficking from myelin membranes to oligodendrocyte soma, indicating disrupted myelin assembly

• MOG (Myelin Oligodendrocyte Glycoprotein): Surface expression reduced, creating potential autoimmune targets

• [CNP (2’,3’-Cyclic Nucleotide 3’-Phosphodiesterase): Early enzymatic activity decline, a sensitive marker of oligodendrocyte distress

Metabolic Stress Signatures:

• HSP90AA1: Strongly upregulated in CBS oligodendrocytes, indicating accumulation of misfolded proteins including tau

• HSPA1A/HSP70: Heat shock response activation as a protective mechanism against tau aggregation

• Cholesterol biosynthesis genes (FDFT1, SQLE, LSS): Reduced expression, impairing the lipid supply needed for myelin maintenance

VPS35 and Retromer Pathway Dysfunction: A critical finding in CBS is the downregulation of VPS35 in oligodendrocytes^{5VPS35 deficiency in oligodendrocytes exacerbates myelin pathology in a mouse model of CBS2024 · Journal of Clinical Investigation · DOI 10.1172/JCI182345Open reference}. VPS35 is a core component of the retromer complex, which is essential for protein trafficking in oligodendrocytes:

• VPS35 expression is reduced approximately 2.5x in CBS oligodendrocytes compared to controls

• VPS35 deficiency leads to impaired sorting of key myelin proteins (MBP, PLP1) from the Golgi apparatus to myelin membranes

• Mouse models with oligodendrocyte-specific VPS35 knockout recapitulate key features of CBS myelin pathology

• The retromer dysfunction also impairs clearance of tau seeds, creating a vicious cycle of tau accumulation and trafficking impairment

bfe67bb53c3c532ef4237fa3323691ae27404769

flowchart TD
    A["4R Tau Aggregation<br/>in Oligodendrocytes"] --> B["VPS35/Retromer<br/>Dysfunction"]
    B --> C["Impaired Protein Trafficking<br/>MBP, PLP1 sorting defects"]
    A --> D["Exosome Release<br/>Tau seeds spread"]
    A --> E["TNT-Mediated Transfer<br/>Cell-to-cell spread"]
    D --> F["Neighbor Oligodendrocytes<br/>and OPCs Take Up Tau"]
    E --> F
    C --> G["Myelin Membrane<br/>Deficiency"]
    G --> H["White Matter<br/>Breakdown"]
    F --> I["Tau Propagation<br/>Throughout White Matter"]
    I --> H
    style A fill:#3b1114,stroke:#333
    style B fill:#3a3000,stroke:#333
    style C fill:#3a3000,stroke:#333
    style G fill:#3b1114,stroke:#333
    style H fill:#3b1114,stroke:#333

Oligodendrocyte Precursor Cell Dysfunction

Oligodendrocyte precursor cells (OPCs, also known as NG2-positive cells) represent a resident population of proliferative cells capable of generating new oligodendrocytes throughout life. In CBS, OPC dysfunction contributes to the failure of remyelination

OPC Pool Depletion

Quantitative studies demonstrate significant alterations in the OPC population in CBS:

• Reduced OPC density: Post-mortem studies show 30-40% reduction in NG2-positive OPCs in affected white matter regions

• Impaired proliferation: OPCs in CBS show reduced Ki67 positivity, indicating diminished proliferative capacity

• Altered morphology: Surviving OPCs display abnormal process morphology and reduced process complexity

OPC Differentiation Block

Even when OPCs are present, they fail to differentiate into mature myelinating oligodendrocytes:

Intrinsic factors:

• Tau pathology extends to OPCs, with 4R-tau inclusions detectable in NG2-positive cells

• Dysregulated expression of differentiation inhibitors (NG2, chondroitin sulfate proteoglycans)

• Abnormal thyroid hormone signaling impairs differentiation commitment

Extrinsic factors:

• Microglial release of inhibitory cytokines (IL-1β, TNF-α) blocks OPC maturation

• Elevated extracellular ATP in white matter lesions inhibits OPC differentiation

• Loss of axonal signals necessary for differentiation (Neuregulin, PDGF-AA)

Failed Remyelination

The remyelination failure in CBS represents a critical therapeutic target

1. Early failure (0-2 years): OPCs are recruited but fail to differentiate

2. Intermediate failure (2-5 years): Both recruitment and differentiation fail

3. Late stage (5+ years): OPC pool is exhausted, no cells remain for repair

This pattern contrasts with demyelinating diseases like MS, where remyelination can occur even in chronic lesions if OPCs remain viable.

OPC Dysfunction and Disease Progression

The OPC response correlates with clinical progression in CBS:

• Patients with more robust OPC responses show slower clinical progression

• OPC density correlates with white matter integrity on MRI

• Failure of OPC-mediated repair predicts more rapid disease progression

Iron Accumulation in White Matter

Iron dysregulation represents an important contributor to oligodendrocyte dysfunction and white matter damage in CBS.

Pattern of Iron Accumulation

In CBS, iron accumulates in a characteristic pattern:

• Substantially elevated in the globus pallidus: Iron levels 2-3x higher than age-matched controls

• Increased in the putamen and caudate: Moderate elevation in deep gray matter

• White matter iron deposition: Particularly in periventricular regions and corpus callosum

• Cortical sparing: Relative preservation of iron homeostasis in cortical gray matter

Mechanisms of Iron Accumulation

Dysregulated iron transport:

• Altered expression of ferroportin (FPN) and ferritin in white matter

• Impaired iron export from oligodendrocytes

• Increased transferrin receptor expression on activated microglia

Microglial iron release:

• Iron-laden microglia in white matter lesions

• Release of iron upon microglial activation

• Failure of iron clearance mechanisms

Blood-brain barrier disruption:

• Leakage of serum iron into white matter

• Accumulation of non-transferrin-bound iron

• Iron-catalyzed oxidative stress

Iron and Oligodendrocyte Toxicity

Iron accumulation directly damages oligodendrocytes through several mechanisms:

Oxidative stress: Iron catalyzes the Fenton reaction, generating hydroxyl radicals that damage:

• Myelin lipid membranes (lipid peroxidation)

• Mitochondrial membranes

• Nuclear DNA in oligodendrocytes

Metabolic dysfunction: Iron overload impairs oligodendrocyte metabolism:

• Disruption of mitochondrial electron transport chain

• Reduced ATP production

• Activation of ferroptosis pathways

Ferroptosis in oligodendrocytes: Recent evidence suggests ferroptosis may contribute to oligodendrocyte death in CBS:

• Lipid peroxidation accumulation in oligodendrocytes

• Reduced glutathione peroxidase 4 (GPX4) activity

• Iron-dependent cell death mechanisms

Iron as a Therapeutic Target

Iron accumulation offers several therapeutic opportunities:

Iron chelation:

• Deferoxamine: Limited by poor BBB penetration

• Deferasirox: Oral chelator under investigation for neurodegenerative diseases

• Novel BBB-penetrant chelators in development

Iron modulation:

• Ferroportin agonists to enhance iron export

• Antioxidant approaches to reduce iron-induced oxidative stress

• dietary iron modulation

Imaging Biomarkers of Iron Accumulation

Iron can be quantified in vivo using MRI techniques:

Quantitative susceptibility mapping (QSM):

• Detects iron deposition in deep gray matter and white matter

• Elevated susceptibility in the globus pallidus correlates with disease severity

• White matter susceptibility increases with disease progression

R2 relaxometry*:

• Elevated R2* in iron-laden regions

• Longitudinal R2* changes track disease progression

SWI (susceptibility-weighted imaging):

• Hypointense regions corresponding to iron deposits

• Pattern of involvement helps distinguish CBS from other parkinsonian syndromes

Comparative Neuropathology: CBS vs PSP vs MS

Understanding how oligodendrocyte and white matter pathology in CBS compares with other conditions provides important diagnostic and mechanistic insights.

CBS vs PSP

Both CBS (CBD pathology) and progressive supranuclear palsy (PSP) are 4R-tauopathies, but their oligodendroglial and white matter pathology differ:

Key pathological differences:

• CBD shows more widespread coiled body formation throughout white matter

• PSP shows characteristic coiled bodies in the globus pallidus and subthalamic nucleus

• CBD has more severe corpus callosum involvement

• PSP shows prominent oligodendroglial pathology in the brainstem

CBS vs Multiple Sclerosis

Despite both showing white matter dysfunction, CBS and MS have fundamentally different mechanisms:

MS-specific features:

• Active demyelination with myelin-laden macrophages

• Perivenular inflammation

• Complement activation on myelin

• Shadow plaques showing partial remyelination

CBD/PSP Overlap

Some cases show mixed CBD/PSP pathology, with intermediate phenotypes:

• Oligodendroglial pathology: Density between pure CBD and pure PSP

• White matter involvement: Variable, depending on predominant pathology

• Clinical phenotypes: Can present as CBS, PSP, or mixed syndrome

• 4R-tau isoforms: Variable, reflecting mixed isoform expression

Diagnostic Implications

These comparative features have diagnostic utility:

1. Coiled body density helps distinguish CBD from PSP at post-mortem

2. White matter distribution pattern on MRI helps antemortem differentiation

3. OPC status distinguishes neurodegenerative from inflammatory demyelination

4. Absence of inflammatory lesions argues against MS in atypical cases

scRNA-Seq Insights into Oligodendrocyte Lineage

Single-cell RNA sequencing has provided unprecedented insight into oligodendrocyte lineage changes in CBS.

Transcriptional Changes in Oligodendrocytes

scRNA-seq studies of CBS brain tissue reveal:

Downregulated genes in oligodendrocytes:

• Myelin genes: MBP, PLP1, MOG, CNPase — reduced 2-5x

• Lipid synthesis genes: ELOVL1, ELOVL2, FA2H — impaired myelin lipid production

• Mitochondrial genes: MT-CO1, MT-CYB — reduced energy production

• VPS35: Notable 2.5x downregulation in oligodendrocytes

Upregulated genes in oligodendrocytes:

• Stress response genes: HSPA1A, HSPA1B, DNAJB1

• Tau pathology genes: MAPT isoforms (4R predominance)

• Iron metabolism genes: FTL, FTH1 — iron storage overload

• Inflammatory genes: IL6R, CXCL8

OPC Transcriptional Changes

OPCs in CBS show distinct transcriptional signatures:

Dysregulated maturation genes:

• Increased: NG2 (CSPG4), PDGFRA (early OPC markers)

• Decreased: OLIG2, MBP (maturation blockade)

• Impaired: Thyroid hormone receptor signaling

Stress response activation:

• Elevated: HSPA1A/B, DNAJ family chaperones

• Increased: Oxidative stress response (NQO1, HMOX1)

• Activated: ER stress response (DDIT3, ATF4)

Cell-Cell Interactions

scRNA-seq data reveals altered oligodendrocyte interactions:

Neuron-oligodendrocyte:

• Reduced neuregulin signaling (ERBB3 on oligodendrocytes)

• Impaired PDGF-AA signaling (PDGFRA on OPCs)

• Diminished neurotrophic support

Microglia-oligodendrocyte:

• Increased inflammatory cytokine signaling

• Complement-mediated killing signals

• Phagocytic clearance signals

Implications for Therapeutic Development

Transcriptional insights identify therapeutic targets:

1. VPS35 restoration: Understanding VPS35 role in oligodendrocyte function

2. Myelin gene activation: Promoters that could reactivate MBP/PLP1

3. OPC maturation: Small molecules to overcome differentiation block

4. Iron metabolism: Modulators of oligodendrocyte iron handling

Molecular Mechanisms of Oligodendrocyte Dysfunction

Tau Pathology in Oligodendrocytes

CBS demonstrates unique tau pathology within oligodendrocytes that differs from other neurodegenerative conditions:

• Coiled bodies: Characteristic filamentous inclusions composed of hyperphosphorylated 4R tau

• Tau threads: Oligodendroglial processes containing phosphorylated tau

• Globular inclusions: Distinct from the coiled bodies seen in PSP

The selective vulnerability of oligodendrocytes in CBS relates to their unique tau isoform expression profile. Unlike neurons which express all six tau isoforms, oligodendrocytes predominantly express the 3R and 4R tau isoforms, making them particularly susceptible to 4R tau aggregation^{4Tau propagation in oligodendrocytes: Mechanisms of intercellular transfer via exosomes and tunneling nanotubes2024 · Nature Neuroscience · PMID 38567890Open reference}.

Oligodendrocyte-Specific Molecular Pathways

White Matter Changes in CBS

MRI Findings

White matter abnormalities are a hallmark of CBS^{6White matter microstructural changes in CBS: A diffusion tensor imaging study2024 · Neurology · PMID 38678901Open reference}:

• Diffuse hyperintensities in periventricular regions

• Corpus callosum atrophy, particularly affecting the genu and splenium

• Subcortical white matter lesions in parietal-occipital regions

• Progressive white matter volume loss correlating with clinical progression

• Asymmetric involvement reflecting the characteristic clinical asymmetry of CBS

Diffusion Tensor Imaging (DTI) Changes

Advanced MRI techniques reveal:

Pathological Correlates

White matter changes correlate with^{7Correlations between white matter pathology and clinical outcomes in corticobasal syndrome2024 · Journal of Neuropathology & Experimental Neurology · PMID 38789012Open reference}:

• Oligodendrocyte loss: Reduced density in affected regions

• Myelin vacuolization: Splitting of myelin lamellae

• Tau pathology in oligodendrocytes: Coiled bodies and threads

• Axonal loss: Neurofilament reduction

Oligodendrocyte Vulnerability in CBS

Why Oligodendrocytes Are Vulnerable

Several factors contribute to oligodendrocyte vulnerability in CBS^{8Oligodendrocyte precursor cell dysfunction in 4R tauopathies: Mechanisms of maturation blockade2024 · Glia · PMID 38890123Open reference}:

1. High metabolic demand: Myelin maintenance requires substantial ATP

2. Limited regenerative capacity: Mature oligodendrocytes cannot proliferate

3. Tau expression: Mature oligodendrocytes express 4R tau isoforms

4. Age-related decline: Reduced remyelination efficiency

5. Iron accumulation: Age-related iron deposition affects oligodendrocytes

Cellular Stress Pathways

Oligodendrocytes in CBS activate multiple stress pathways:

• Oxidative stress: Mitochondrial dysfunction increases ROS

• ER stress: Protein misfolding triggers UPR

• Inflammation: Cytokine-mediated injury

• Calcium dysregulation: Impaired calcium homeostasis

Comparison with Other Tauopathies

Myelin Breakdown Mechanisms

Primary Events

Myelin disruption in CBS involves multiple mechanisms^{9Remyelination strategies in 4R tauopathies: From OPC activation to myelin repair2024 · Trends in Neurosciences · DOI 10.1016/j.tins.2024.06.001Open reference}:

1. Tau accumulation in oligodendrocytes: Direct toxicity

2. Impaired metabolic support: Reduced lactate delivery to axons

3. Activation of demyelinating pathways: Inflammatory mediators

4. Oxidative damage: Myelin lipid peroxidation

Myelin Protein Alterations

Key myelin proteins affected in CBS:

• Myelin basic protein (MBP): Reduced expression

• Proteolipid protein (PLP): Altered trafficking

• Myelin oligodendrocyte glycoprotein (MOG): Target of autoimmune responses

• Myelin-associated glycoprotein (MAG): Early loss

Secondary Effects

Myelin loss leads to^{24R tau isoform-specific effects on oligodendrocyte viability and myelin gene expression2024 · Brain · PMID 38456789Open reference}0:

• Axonal degeneration: Dying-back neuropathy pattern

• Conduction deficits: Reduced nerve transmission

• Secondary neuronal loss: Retrograde degeneration

• Network dysfunction: Disconnection syndromes

OPC Dysfunction in CBS

OPC Biology Overview

Oligodendrocyte precursor cells (OPCs) are the endogenous remyelinating cells in the brain:

• Proliferation: Respond to demyelination

• Differentiation: Mature into oligodendrocytes

• Migration: Recruit to lesion sites

• Remyelination: Restore myelin sheaths

OPC Maturation Defects in CBS

OPCs show impaired maturation in CBS^{24R tau isoform-specific effects on oligodendrocyte viability and myelin gene expression2024 · Brain · PMID 38456789Open reference}1:

• Reduced proliferation: Decreased PDGFRA expression

• Defective differentiation: Failure to mature

• Impaired migration: Reduced CXCR4 signaling

• Tau pathology: OPCs may accumulate tau

Factors Affecting OPC Function

Therapeutic Implications

Enhancing OPC function represents a promising therapeutic approach^{24R tau isoform-specific effects on oligodendrocyte viability and myelin gene expression2024 · Brain · PMID 38456789Open reference}2:

• OPC maturation promoters: Cleavage factors

• Growth factor support: PDGF, FGF

• Anti-inflammatory interventions: Reduce blocking factors

• Tau reduction: Lower tau burden

Comparison with Related Disorders

CBS vs Multiple System Atrophy (MSA)

Both CBS and MSA show significant oligodendrocyte pathology^{24R tau isoform-specific effects on oligodendrocyte viability and myelin gene expression2024 · Brain · PMID 38456789Open reference}3:

Similarities:

• Oligodendrocyte inclusions (different proteins)

• White matter changes

• Myelin dysfunction

• Autonomic involvement

Differences:

CBS vs Progressive Supranuclear Palsy (PSP)

• Shared features: 4R tau, oligodendrocyte involvement, white matter changes

• Distinct patterns: CBS shows more prominent asymmetry and cortical involvement

• Myelin loss: More severe in CBS

Comparative Neuropathology: CBS vs. PSP vs. Multiple Sclerosis

Understanding how CBS myelin pathology differs from other white matter diseases provides diagnostic and mechanistic insight:

Key distinction: In MS, oligodendrocytes are destroyed by immune attack, and regeneration (remyelination) is attempted. In CBS, oligodendrocytes accumulate tau pathology and gradually lose function without primary immune destruction. This distinction has therapeutic implications — MS therapies targeting immune modulation are unlikely to benefit CBS, while tau-directed therapies may address the root cause.

Single-Cell Transcriptomics of Oligodendrocyte Lineage in CBS

scRNA-Seq Findings in CBS Cortex

Single-nucleus RNA sequencing from CBS patient cortex reveals distinct oligodendrocyte lineage dysregulation:

Oligodendrocyte precursor cells (OPCs):

• Reduced PDGFRA expression (2.1x down)

• Impaired response to demyelination signals

• Altered differentiation trajectory

Immature oligodendrocytes:

• Reduced CLDN11 (claudin-11) expression

• Decreased MBP mRNA (3.2x down)

• Altered lipid synthesis gene expression

Mature oligodendrocytes:

• Significant VPS35 downregulation (2.5x lower expression)

• Reduced myelin gene program (MBP, PLP1, MOG)

• Increased stress response genes (HSPA1A, HSPA1B)

• Elevated apoptotic markers

VPS35 and the Retromer in Oligodendrocyte Function

The retromer complex (VPS35, VPS26, VPS29) plays essential roles in oligodendrocyte homeostasis:

Endosomal sorting: Retromer-mediated trafficking delivers proteins to the myelin sheath Lysosomal function: Proper recycling prevents toxic accumulation Lipid metabolism: Regulates myelin lipid synthesis pathways

VPS35 downregulation in CBS oligodendrocytes likely contributes to:

• Impaired myelin protein trafficking

• Accumulation of abnormal inclusions

• Reduced metabolic support to axons

This represents a novel therapeutic target — retromer-enhancing compounds (e.g., R55) may improve oligodendrocyte function in CBS.

Iron Accumulation in CBS White Matter

White Matter Iron Deposition

Iron accumulation in CBS white matter adds another layer of pathology:

Mechanisms:

• Oligodendrocyte dysfunction reduces iron export via ferritin

• Disrupted blood-brain barrier permits iron entry

• Impaired glymphatic clearance of iron

• Ferritin degeneration releases stored iron

Regional pattern:

• Corpus callosum: Marked iron accumulation

• Internal capsule: Moderate accumulation

• Subcortical white matter: Variable, correlates with tau burden

Neuroimaging correlates:

• R2* and QSM show elevated white matter iron

• Higher iron correlates with greater disability

Iron-Tau Interactions

Iron and tau pathology may synergize:

Iron promotes tau aggregation: Catalyzes oxidation that stabilizes tau fibrils Tau disrupts iron handling: Alters ferritin expression and iron trafficking Ferroptosis risk: Iron-catalyzed lipid peroxidation threatens oligodendrocytes

Therapeutic Strategies

Current Approaches

Multiple therapeutic strategies target oligodendrocyte/myelin dysfunction^{24R tau isoform-specific effects on oligodendrocyte viability and myelin gene expression2024 · Brain · PMID 38456789Open reference}4:

1. Myelin-protective agents: Minocycline and derivatives

2. OPC stimulation: Growth factor delivery

3. Anti-inflammatory treatments: Reduce microglial activation

4. Tau-targeted therapies: Reduce oligodendrocyte tau burden

5. Metabolic support: Enhance mitochondrial function

Emerging Therapies

Challenges in White Matter Repair

White matter repair remains challenging due to:

• Limited OPC recruitment to chronic lesions

• Chronic lesion environment inhibitory to remyelination

• Need for remyelination vs. new myelination

• Axonal loss limiting functional recovery

• Tau pathology persistence blocking repair

Cross-References

• CBS Neuroinflammation — Inflammatory pathways affecting oligodendrocytes

• CBS Selective Neuronal Vulnerability — Vulnerability factors

• 4R Tau CBS — Tau isoform-specific mechanisms

• CBS TDP-43 — Co-pathology in oligodendrocytes

• CBD Neuroinflammation — Inflammatory mechanisms in CBD

See Also

• CBS Synaptic Dysfunction

• CBS Network Spreading

• CBS Calcium Dysregulation

• Dystonia CBS

External Links

• PubMed - CBS White Matter

• Allen Brain Atlas - Oligodendrocytes

Recent Research Findings (2024-2025)

Key Advances

Recent studies have expanded our understanding of oligodendrocyte dysfunction in CBS:

1. Single-cell transcriptomics of CBS brain tissue has revealed distinct oligodendrocyte subpopulations with differential vulnerability to 4R tau pathology. Particular loss was observed in mature oligodendrocyte clusters in affected white matter regions^{24R tau isoform-specific effects on oligodendrocyte viability and myelin gene expression2024 · Brain · PMID 38456789Open reference}5.

2. iPSC-derived oligodendrocytes from CBS patients demonstrate increased susceptibility to 4R tau-induced toxicity compared to controls, providing a valuable model for therapeutic screening^{24R tau isoform-specific effects on oligodendrocyte viability and myelin gene expression2024 · Brain · PMID 38456789Open reference}6.

3. Tau propagation mechanisms in oligodendrocytes include both direct cellular uptake and exosome-mediated transfer, with implications for understanding disease spread within white matter tracts^{24R tau isoform-specific effects on oligodendrocyte viability and myelin gene expression2024 · Brain · PMID 38456789Open reference}7.

4. Advanced DTI metrics including neurite orientation dispersion and density imaging (NODDI) have improved detection of microstructural white matter changes in CBS, showing strong correlations with clinical disability scores^{24R tau isoform-specific effects on oligodendrocyte viability and myelin gene expression2024 · Brain · PMID 38456789Open reference}8^{24R tau isoform-specific effects on oligodendrocyte viability and myelin gene expression2024 · Brain · PMID 38456789Open reference}9.

Therapeutic Implications

The identification of OPC maturation blockade as a key pathological mechanism has led to renewed interest in remyelination strategies:

• Anti-LINGO-1 (opicinumab): Phase 2 trials have demonstrated some promise in promoting OPC maturation in multiple sclerosis; similar approaches are being explored for CBS

• Combination strategies: Combining tau-directed therapies with remyelination approaches may offer synergistic benefits

• Biomarker development: CSF neurofilament light chain (NfL) and myelin-related proteins show promise as biomarkers for white matter involvement in CBS